We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-5.11%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$10.4B
AUM Growth
-$929M
Cap. Flow
-$275M
Cap. Flow %
-2.65%
Top 10 Hldgs %
43.03%
Holding
1,068
New
166
Increased
266
Reduced
450
Closed
162

Sector Composition

Rank Sector Weight
1 Energy 50.72%
2 Financials 11.42%
3 Technology 6.62%
4 Healthcare 4.85%
5 Consumer Discretionary 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYZ
176
Block Inc
XYZ
$45.9B
$4.96M 0.05%
20,679
-995
-5% -$256K
BSX icon
177
Boston Scientific
BSX
$65.8B
$4.74M 0.05%
109,289
-363
-0.3% -$16.1K
IOVA icon
178
Iovance Biotherapeutics
IOVA
$2.23B
$4.69M 0.05%
190,019
-10,411
-5% -$245K
AMTX icon
179
Aemetis
AMTX
$119M
$4.62M 0.04%
252,585
+34,572
+16% +$382K
FIS icon
180
Fidelity National Information Services
FIS
$21.5B
$4.55M 0.04%
37,381
+1,246
+3% +$167K
ARNA
181
DELISTED
Arena Pharmaceuticals Inc
ARNA
$4.46M 0.04%
74,855
-4,786
-6% -$283K
KRTX
182
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$4.43M 0.04%
36,219
-2,478
-6% -$286K
ETRN
183
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$4.41M 0.04%
435,235
-32,898
-7% -$290K
IEA
184
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$4.29M 0.04%
375,577
+202,939
+118% +$2.49M
RMO
185
DELISTED
Romeo Power, Inc.
RMO
$4.25M 0.04%
859,416
+137,246
+19% +$821K
TMO icon
186
Thermo Fisher Scientific
TMO
$211B
$4.05M 0.04%
7,096
-263
-4% -$144K
ORCL icon
187
Oracle
ORCL
$331B
$3.98M 0.04%
45,622
-2,577
-5% -$228K
AM icon
188
Antero Midstream
AM
$10.8B
$3.94M 0.04%
378,263
-28,565
-7% -$280K
PRTA icon
189
Prothena Corp
PRTA
$458M
$3.93M 0.04%
55,206
-2,674
-5% -$166K
CRM icon
190
Salesforce
CRM
$134B
$3.93M 0.04%
14,487
-2,002
-12% -$508K
LLY icon
191
Eli Lilly
LLY
$1.07T
$3.87M 0.04%
16,760
-887
-5% -$219K
PPLI
192
People Inc
PPLI
$3.1B
$3.87M 0.04%
36,216
+670
+2% +$73.8K
AVGO icon
193
Broadcom
AVGO
$1.82T
$3.83M 0.04%
78,970
-2,150
-3% -$105K
SWTX
194
DELISTED
SpringWorks Therapeutics
SWTX
$3.82M 0.04%
60,214
-4,102
-6% -$316K
CYTK icon
195
Cytokinetics
CYTK
$11B
$3.66M 0.04%
102,354
+7,862
+8% +$231K
ALXO icon
196
ALX Oncology
ALXO
$273M
$3.65M 0.04%
49,448
-3,234
-6% -$216K
LBRDK icon
197
Liberty Broadband Class C
LBRDK
$4.15B
$3.55M 0.03%
20,550
+3,450
+20% +$621K
APLS
198
DELISTED
Apellis Pharmaceuticals
APLS
$3.52M 0.03%
106,632
+1,008
+1% +$56.6K
AMSC icon
199
American Superconductor
AMSC
$1.48B
$3.49M 0.03%
239,081
+31,921
+15% +$442K
AUPH icon
200
Aurinia Pharmaceuticals
AUPH
$1.97B
$3.48M 0.03%
157,076
-10,525
-6% -$167K

Similar funds

ALPS Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, ALPS Advisors held 1,068 positions worth $10.4B, down 8.2% from $11.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

ALPS Advisors's Q3 2021 filing shows 166 new, 266 increased, 450 reduced and 162 closed positions. Its largest new stake was Stem: 59,506 shares worth $28.4M. The largest sale was MPLX, an estimated $69.6M.

By sector, the portfolio is most concentrated in Energy at 51% of assets, down from 53% a quarter earlier, followed by Financials and Technology.

  • ALPS Advisors's largest Q3 2021 buy was Stem: 59,506 shares worth $28.4M.
  • ALPS Advisors added most to ENLINK MIDSTREAM, LLC in Q3 2021, an estimated $39.9M increase.
  • ALPS Advisors's biggest Q3 2021 reduction was MPLX, cutting an estimated $69.6M.
  • ALPS Advisors fully exited Universal Display in Q3 2021, selling an estimated $47.2M.
  • ALPS Advisors's ten largest holdings make up 43% of its $10.4B portfolio in Q3 2021.
  • ALPS Advisors opened 166 new positions and closed 162 in Q3 2021.
  • ALPS Advisors's portfolio value fell 8.2% quarter-over-quarter to $10.4B.

Based on ALPS Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.